Parade aims to feature only the best products and services. If you buy something via one o...
If you've ever taken a psychology class, you've probably heard the name William James. Bor...
A new narrative about Iran’s leadership mistakes continuity for change - and echoes the re...
Ruling against Ben Jamal and Chris Nineham will spawn a 'broader chilling effect', groups...
Ukrainian officials say residential buildings and bulk carrier also hit in overnight assau...
Countries
Opinion
California Governor’s debate reveals major problem — as all the candidates are ranked
Mamdani made Ken Griffin a target — and cemented NYC’s death spiral
Murphy’s ‘sarcastic’ post: Letters to the Editor — April 24, 2026
Mamdani & Chi Ossé’s performances this week prove they’re in the wrong field
Teen girl stomped on NYC street shows a generation abandoned to phones and porn
-
Independent ( Yemen ) 2026/4/2The FDA authorized Eli Lilly's drug as part of a new program aimed at cutting drug approval times
-
PR Newswire ( Middle East ) 2026/3/28Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz mon...
-
Gizmodo ( Middle East ) 2026/1/9People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.
-
Quartz ( Middle East ) 2025/10/6European Association for the Study of Obesity says the drugs are so effective, they should be used for almost all obesity patients
-
Los Angeles Daily News ( Middle East ) 2025/5/12By Naomi Kresge | BloombergEli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nord...
-
Quartz ( Middle East ) 2025/5/12Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s d...
-
News10NBC ( Middle East ) 2025/5/12People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head...
-
Quartz ( Middle East ) 2025/4/1Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and...
- Ukiah Daily Journal ( Middle East ) 2025/3/5
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance.Related ArticlesHealth |...
